ArticleCancer cell international2024

Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.

Federica Iannelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.